Multiple-Dose, Double-Blind, Placebo-Controlled, Crossover Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Sodium Oxybate (Xyrem) in Subjects With Moderate to Severe Essential Tremor.
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2012
At a glance
- Drugs Sodium oxybate (Primary)
- Indications Essential tremor
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Jazz Pharmaceuticals Inc
- 04 Jul 2012 Additional location (France) added as reported by European Clinical Trials Database record.
- 10 Jun 2009 Actual patient number (19) added as reported by ClinicalTrials.gov.
- 10 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.